Molecular origins for the dominant negative function of human glucocorticoid receptor beta

被引:126
作者
Yudt, MR
Jewell, CM
Bienstock, RJ
Cidlowski, JA
机构
[1] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1128/MCB.23.12.4319-4330.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study molecularly elucidates the basis for the dominant negative mechanism of the glucocorticoid receptor (GR) isoform hGRbeta, whose overexpression is associated with human glucocorticoid resistance. Using a series of truncated hGRalpha mutants and sequential mutagenesis to generate a series of hGRalpha/beta hybrids, we find that the absence of helix 12 is neither necessary nor sufficient for the GR dominant negative phenotype. Moreover, we have localized the dominant negative activity of hGRbeta to two residues and found that nuclear localization, in addition to heterodimerization, is a critical feature of the dominant negative activity. Molecular modeling of wild-type and mutant hGRalpha and hGRbeta provides structural insight and a potential physical explanation for the lack of hormone binding and the dominant negative actions of hGRbeta.
引用
收藏
页码:4319 / 4330
页数:12
相关论文
共 49 条
[1]  
ALLGOOD VE, 1993, J BIOL CHEM, V268, P20870
[2]   Exploiting the past and the future in protein secondary structure prediction [J].
Baldi, P ;
Brunak, S ;
Frasconi, P ;
Soda, G ;
Pollastri, G .
BIOINFORMATICS, 1999, 15 (11) :937-946
[3]   GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS [J].
BAMBERGER, CM ;
BAMBERGER, AM ;
DECASTRO, M ;
CHROUSOS, GP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2435-2441
[4]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[5]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[6]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[7]   Glucocorticoid resistant syndromes - Molecular basis and clinical presentations [J].
Bronnegard, M ;
Stierna, P ;
Marcus, C .
JOURNAL OF NEUROENDOCRINOLOGY, 1996, 8 (06) :405-415
[8]   TARGETED DISRUPTION OF THE GLUCOCORTICOID RECEPTOR GENE BLOCKS ADRENERGIC CHROMAFFIN CELL-DEVELOPMENT AND SEVERELY RETARDS LUNG MATURATION [J].
COLE, TJ ;
BLENDY, JA ;
MONAGHAN, AP ;
KRIEGLSTEIN, K ;
SCHMID, W ;
AGUZZI, A ;
FANTUZZI, G ;
HUMMLER, E ;
UNSICKER, K ;
SCHUTZ, G .
GENES & DEVELOPMENT, 1995, 9 (13) :1608-1621
[9]   PROTEIN ENCODED BY V-ERBA FUNCTIONS AS A THYROID-HORMONE RECEPTOR ANTAGONIST [J].
DAMM, K ;
THOMPSON, CC ;
EVANS, RM .
NATURE, 1989, 339 (6226) :593-597
[10]   ANTHEPROT:: An integrated protein sequence analysis software with client/server capabilities [J].
Deléage, G ;
Combet, C ;
Blanchet, C ;
Geourjon, C .
COMPUTERS IN BIOLOGY AND MEDICINE, 2001, 31 (04) :259-267